June 30, 2008
Doug Berger, M.D., Ph.D. Modern pharmaceutical drug development and commercialization is more and more dependent on sharing of technology and infrastructure. Partnering is often key for small-to-midsize global pharma companies who do not have a development or commercial organization in...read more